GKOS(Glaukos Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $294.01M | $282.86M | $314.71M | $383.48M | $507.44M |
| 毛利润 | $227.38M | $213.88M | $239.14M | $289.45M | $282.76M |
| 营业利润 | −$32.87M | −$82.31M | −$128.70M | −$122.37M | −$199.60M |
| 净利润 | −$49.59M | −$99.19M | −$134.66M | −$146.37M | −$187.69M |
| 经营现金流 | $24.71M | −$33.08M | −$57.76M | −$61.32M | −$14.79M |
| 自由现金流 | −$23.08M | −$63.35M | −$78.01M | −$67.62M | −$22.45M |
| 摊薄每股收益 | $-1.07 | $-2.09 | $-2.78 | $-2.77 | $-3.28 |